Status: Recruiting
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
The aim is to compare the rate of hypertensive subjects with ICH who reach SBP target with stability within 60 minutes of enrollment, among patients treated with IV clevidipine with those treated with alternate IV antihypertensive regimen.
Participants needed: 1,000
Trial details
Age: 18-100Biological sex: AllType: ObservationalSponsor: Zeenat Qureshi Stroke InstituteUpdated: Jun 26, 2026Locations: 16
Eligibility criteria
Age 18 years or older and less than 100 years. [+10]
Time of symptom onset cannot be reliably assessed. [+12]